Michael L. Cleary

29.7k citations

206 papers · 23.2k indexed · 7 hit papers · h-index 84

Impact in

Hematology top 0.05%
- Acute Myeloid Leukemia Research
Genetics top 0.1%
- Chronic Lymphocytic Leukemia Research

Papers in

Hematology 74
- Acute Myeloid Leukemia Research 59
Genetics 31
- Chronic Lymphocytic Leukemia Research 26

Co-authors: Jeffrey Sklar Paul M. Ayton Roger A. Warnke Stephen D. Smith Tim C. P. Somervaille Akihiko Yokoyama Douglas Tkachuk Jamison L. Nourse
Journals: Blood (29 papers)Molecular and Cellular Biology (25 papers)Cell (11 papers)Cancer Cell (10 papers)New England Journal of Medicine (7 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Michael L. Cleary

204 papers receiving 22.7k citations

Hit Papers

7 papers align trajectories log scale

Leukemia Proto-Oncoprotein MLL Forms a SET1-Like Histone Methyltransferase Complex with Menin To Regulate Hox Gene Expression 2004 · 534 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2004 Molecular and Cellular Biology
2001 Nature
1992 Cell
1990 Cell
1987 New England Journal of Medicine
1986 Cell
1985 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Michael L. Cleary

Since Specialization

Citations

This map shows the geographic impact of Michael L. Cleary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael L. Cleary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael L. Cleary more than expected).

Fields of papers citing papers by Michael L. Cleary

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael L. Cleary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael L. Cleary. The network helps show where Michael L. Cleary may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael L. Cleary, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael L. Cleary Line = papers co-authored together Michael L. Cleary links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Early-life infection depletes preleukemic cells in a mouse model of hyperdiploid B-cell acute lymphoblastic leukemia Blood ·Ali Farrokhi, Tanmaya Atre, Samuel Salitra, Maryam Aletaha, Ana Márquez, Matthew Gynn, Mario Fidanza, Sumin Jo, Nina Rolf, K. E. Simmons, Jesús Duque‐Afonso, Michael L. Cleary, Alix E. Seif, Tobias R. Kollmann, Soren Gantt, Gregor S. D. Reid	2024	0
2	Functional Characterization of Transforming Growth Factor-β Signaling in Dasatinib Resistance and Pre-BCR+ Acute Lymphoblastic Leukemia Cancers ·Gila Mostufi-Zadeh-Haghighi, Pia Veratti, Kyra Zodel, Gabriele Greve, Miguel Waterhouse, Robert Zeiser, Michael L. Cleary, Michael Lübbert, Jesús Duque‐Afonso	2023	1
3	Age and ligand specificity influence the outcome of pathogen engagement on preleukemic and leukemic B-cell precursor populations Blood Advances ·Tanmaya Atre, Ali Farrokhi, Sumin Jo, Samuel Salitra, Jesús Duque‐Afonso, Michael L. Cleary, Nina Rolf, Gregor S. D. Reid	2023	1
4	CBP Modulates Sensitivity to Dasatinib in Pre-BCR+ Acute Lymphoblastic Leukemia Cancer Research ·Jesús Duque‐Afonso, Chiou-Hong Lin, Kyuho Han, David W. Morgens, Edwin E. Jeng, Ziming Weng, Johan Jeong, Stephen H.K. Wong, Li Zhu, Michael C. Wei, Hee-Don Chae, Martin Schrappe, Gunnar Cario, Justus Duyster, Xiangshu Xiao, Kathleen M. Sakamoto, Michael C. Bassik, Michael L. Cleary	2018	12
5	ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL Leukemia Cancer Discovery ·Li Zhu, Qin Li, Stephen H.K. Wong, Min Huang, Brianna J. Klein, Jinfeng Shen, Larissa Ikenouye, Masayuki Onishi, Dominik Schneidawind, Corina Buechele, Loren Hansen, Jesús Duque‐Afonso, Fangfang Zhu, Glòria Mas Martín, Or Gozani, Ravindra Majeti, Tatiana G. Kutateladze, Michael L. Cleary	2016	112
6	E2A-PBX1 Remodels Oncogenic Signaling Networks in B-cell Precursor Acute Lymphoid Leukemia Cancer Research ·Jesús Duque‐Afonso, Chiou-Hong Lin, Kerry Han, Michael C. Wei, Jue Feng, Jason H. Kurzer, Corina Schneidawind, Stephen Hon-Kit Wong, Michael C. Bassik, Michael L. Cleary	2016	27
7	CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid Leukemia Cell stem cell ·Masayuki Iwasaki, Michaela Liedtke, Andrew J. Gentles, Michael L. Cleary	2015	89
8	Molecular Mechanism of MLL PHD3 and RNA Recognition by the Cyp33 RRM Domain Journal of Molecular Biology ·Robert A. Hom, Pei-Yun Chang, Siddhartha Roy, Catherine A. Musselman, Karen C. Glass, Anna I. Selezneva, Or Gozani, Rustem F. Ismagilov, Michael L. Cleary, Tatiana G. Kutateladze	2010	34
9	Menin Critically Links MLL Proteins with LEDGF on Cancer-Associated Target Genes Cancer Cell ·Akihiko Yokoyama, Michael L. Cleary	2008	400
10	Set Domain-Dependent Regulation of Transcriptional Silencing and Growth Control by SUV39H1, a Mammalian Ortholog of Drosophila Su(var)3-9 Molecular and Cellular Biology ·Ron Firestein, Xiangmin Cui, Phil Huie, Michael L. Cleary	2000	96
11	CREB Binding Protein Interacts with Nucleoporin-Specific FG Repeats That Activate Transcription and Mediate NUP98-HOXA9 Oncogenicity Molecular and Cellular Biology ·Lawryn H. Kasper, Paul K. Brindle, Catherine A. Schnabel, Colin E.J. Pritchard, Michael L. Cleary, Jan M. A. van Deursen	1999	271
12	The Oncogenic Capacity of HRX-ENL Requires the Transcriptional Transactivation Activity of ENL and the DNA Binding Motifs of HRX Molecular and Cellular Biology ·Robert K. Slany, Catherine Lavau, Michael L. Cleary	1998	197
13	The Hox Cooperativity Motif of the Chimeric Oncoprotein E2a-Pbx1 Is Necessary and Sufficient for Oncogenesis Molecular and Cellular Biology ·Ching‐Pin Chang, Immaculata De Vivo, Michael L. Cleary	1997	50
14	Disruption of a Homolog of Trithorax by 11q23 Translocations: Leukemogenic and Transcriptional Implications Current topics in microbiology and immunology ·Paul Waring, Michael L. Cleary	1997	42
15	Pim1 cooperates with E2a-Pbx1 to facilitate the progression of thymic lymphomas in transgenic mice Oncogene ·Brian J. Feldman, Tony R. Reid, Michael L. Cleary	1997	26
16	DNA-Confirmed Taenia Solium Cysticercosis in Black Bears (Ursus Americanus) from California American Journal of Tropical Medicine and Hygiene ·Jerold H. Theis, Michael L. Cleary, Michael Syvanen, Arlette Gilson, Pamela K. Swift, Jim Banks, Eileen Johnson	1996	13
17	Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice Cell ·Douglas A. Dedera, Edmund K. Waller, David P. LeBrun, Anish Sen-Majumdar, Mary E. Stevens, Gregory S. Barsh, Michael L. Cleary	1993	170
18	Structure, chromosome mapping, and expression of the mouse Lyl-1 gene. PubMed ·Sophia S. Kuo, Julia D. Mellentin, Neal G. Copeland, Debra J. Gilbert, Nancy A. Jenkins, Michael L. Cleary	1991	37
19	Mapping of translocation breakpoints on the short arm of chromosome 19 in acute leukemias by in situ hybridization Genes Chromosomes and Cancer ·David L. Saltman, Julia D. Mellentin, Stephen D. Smith, Michael L. Cleary	1990	11
20	Frequent biclonality and Ig gene alterations among B cell lymphomas that show multiple histologic forms. The Journal of Experimental Medicine ·Mark Siegelman, Michael L. Cleary, R Warnke, J Sklar	1985	80

About Michael L. Cleary

Michael L. Cleary is a scholar working on Hematology, Genetics, Molecular Biology, Oncology and Pathology and Forensic Medicine, having authored 206 papers that have together received 23.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (59 papers), Genomics and Chromatin Dynamics (34 papers), Acute Lymphoblastic Leukemia research (31 papers), Cancer-related gene regulation (30 papers), Protein Degradation and Inhibitors (29 papers), Chronic Lymphocytic Leukemia Research (26 papers), Epigenetics and DNA Methylation (25 papers) and Lymphoma Diagnosis and Treatment (19 papers). The work is most often cited by research in Hematology (5.6k citations), Genetics (2.9k citations), Molecular Biology (15.3k citations), Pathology and Forensic Medicine (3.3k citations) and Oncology (4.3k citations). Michael L. Cleary has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Jeffrey Sklar, Paul M. Ayton, Roger A. Warnke, Stephen D. Smith, Tim C. P. Somervaille, Akihiko Yokoyama, Douglas Tkachuk, Jamison L. Nourse, Naomi Galili and Sabine Köhler. Their work appears in journals such as Blood, Molecular and Cellular Biology, Cell, Cancer Cell and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact